Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

News

FDIC Said to Move Toward Breakup Plan for Silicon Valley Bank

-Bloomberg https://www.bloomberg.com/news/articles/2023-03-19/fdic-said-to-move-toward-breakup-plan-for-silicon-valley-bank

byCharles Gross

March 19, 2023

1 minute read

-Bloomberg

https://www.bloomberg.com/news/articles/2023-03-19/fdic-said-to-move-toward-breakup-plan-for-silicon-valley-bank

BMO Capital Maintains Market Perform on Royal Gold, Raises Price Target to $145

By Benzinga Newsdesk

Today, 4:22 PM

BMO Capital analyst Jackie Przybylowski maintains Royal Gold (NASDAQ:RGLD) with a Market Perform and raises the price target from $138 to $145.

RGLD

Stifel Downgrades eFFECTOR Therapeutics to Hold, Lowers Price Target to $6.2

By Benzinga Newsdesk

Today, 4:22 PM

Stifel analyst Benjamin Burnett downgrades eFFECTOR Therapeutics (NASDAQ:EFTR) from Buy to Hold and lowers the price target from $20 to $6.2.

EFTR

Morgan Stanley Maintains Underweight on Omnicom Group, Raises Price Target to $79

By Benzinga Newsdesk

Today, 4:22 PM

Morgan Stanley analyst Benjamin Swinburne maintains Omnicom Group (NYSE:OMC) with a Underweight and raises the price target from $67 to $79.

OMC

Why Did Myovant Sciences Shares Fall Despite Q2 Earnings Beat?

By Vandana Singh

Today, 4:22 PM

Tucked in its Q2 earnings release, Myovant Sciences Ltd (NYSE: MYOV) said that Pfizer Inc (NYSE: PFE) has notified its option decision for international rights to relugolix in oncology.

MYOV

FDIC Said to Move Toward Breakup Plan for Silicon Valley Bank

Related Posts

BMO Capital Maintains Market Perform on Royal Gold, Raises Price Target to $145

Stifel Downgrades eFFECTOR Therapeutics to Hold, Lowers Price Target to $6.2

Morgan Stanley Maintains Underweight on Omnicom Group, Raises Price Target to $79

Why Did Myovant Sciences Shares Fall Despite Q2 Earnings Beat?